795-83-5

Basic information

• Product Name: (17beta)-17-hydroxy-4-methylandrost-4-en-3-one
• Synonyms: 17.beta.-Hydroxy-4-methyl-androst-4-en-3-one; 17beta-Hydroxy-4-methylandrost-4-en-3-one; 4-Methyltestosterone; androst-4-en-3-one, 17-hydroxy-4-methyl-, (17beta)-
• CAS NO: 795-83-5
• Molecular Formula: C₂₀H₃₀O₂
• Molecular Weight: 302.451
• Mol File: 795-83-5.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 436.8°C at 760 mmHg
• Flash Point: 186.3°C
• Density: 1.1g/cm³
• Vapor Pressure: 1.83E-09mmHg at 25°C
• Refractive Index: 1.554
• CAS DataBase Reference: (17beta)-17-hydroxy-4-methylandrost-4-en-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: (17beta)-17-hydroxy-4-methylandrost-4-en-3-one(795-83-5)
• EPA Substance Registry System: (17beta)-17-hydroxy-4-methylandrost-4-en-3-one(795-83-5)

Safety Data

• Hazardous Substances Data: 795-83-5(Hazardous Substances Data)

Usage

Description

(17beta)-17-hydroxy-4-methylandrost-4-en-3-one, also known as Methyltestosterone, is a synthetic androgen hormone that belongs to the class of anabolic steroids. It is derived from testosterone and is commonly used in medical settings to stimulate the development of male secondary sexual characteristics and treat conditions such as low testosterone levels and delayed puberty in males.
Used in Pharmaceutical Industry:
(17beta)-17-hydroxy-4-methylandrost-4-en-3-one is used as a pharmaceutical agent for the treatment of low testosterone levels and delayed puberty in males. It is used as a hormone replacement therapy to stimulate the development of male secondary sexual characteristics.
Used in Oncology:
(17beta)-17-hydroxy-4-methylandrost-4-en-3-one is used as a therapeutic agent for the treatment of breast cancer in women. It works by binding to androgen receptors in the body, inhibiting the growth of breast cancer cells.
Used in Sports:
(17beta)-17-hydroxy-4-methylandrost-4-en-3-one is used as a performance-enhancing drug in sports. It promotes protein synthesis and muscle growth, enhancing athletic performance.
However, it is important to note that the use of (17beta)-17-hydroxy-4-methylandrost-4-en-3-one is regulated and controlled due to its potential for abuse and misuse, as well as its association with several potential side effects, such as liver damage, cardiovascular problems, and hormonal imbalances.

Upstream product

• 13452-06-7 4-hydroxy-3-oxo-4-androsten-17β-yl acetate 
• 571-22-2 5β-androstan-17β-ol-3-one 
• 925-90-6 ethylmagnesium bromide 
• 1458-92-0 17β-acetoxy-4-oxa-androst-5-en-3-one 
• 58-22-0 testosterone 
• 74-88-4 methyl iodide 
• 50300-23-7 (3R,4S,8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-3,17-bis-trimethylsilanyloxy-1,2,3,4,7,8,9,10,11,12,13,14,15,16,17,20-hexadecahydro-cyclopropa[3,4]cyclopenta[a]phenanthrene 
• 1759-35-9 5-oxo-A-nor-3,5-seco-17β-hydroxy-androstan-3-oic acid 
• 25495-26-5 3,17β-Bis<(trimethylsilyl)oxy>-3,5-androstadiene 
• 71996-13-9 17β-benzoyloxy-4-oxa-androst-5-en-3-one 

Downstream Products

• 10147-53-2 17β-Hydroxy-4α-methyl-5α-androstan-3-on 

Relevant articles and documents

Partial synthesis of quassin: Synthesis of a key intermediate with an angular 8β-methyl group from testosterone

-